Cogstate Limited
ASX:CGS.AX
Overview | Financials
Company Name | Cogstate Limited |
Symbol | CGS.AX |
Currency | AUD |
Price | 0.96 |
Market Cap | 165,691,200 |
Dividend Yield | 0% |
52-week-range | 0.795 - 1.595 |
Industry | Health Information Services |
Sector | Healthcare |
CEO | Mr. Bradley John O'Connor B.Bus, C.A., CA |
Website | https://www.cogstate.com |
An error occurred while fetching data.
About Cogstate Limited
Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD